

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb277</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Embryonic Stem Cell Conditioned Medium Supports In Vitro Maturation of Mouse Oocytes</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Miraki</surname><given-names>Saber</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mokarizadeh</surname><given-names>Aram</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Banafshi</surname><given-names>Omid</given-names></name></contrib><aff>Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Assadollahi</surname><given-names>Vahideh</given-names></name></contrib><aff>Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Abdi</surname><given-names>Mahdad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Roshani</surname><given-names>Daem</given-names></name></contrib><aff>Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fathi</surname><given-names>Fardin</given-names></name></contrib><aff>Department of Biology, Faculty of Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran</aff><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>9</volume>
      <issue>3</issue>
      <fpage>114</fpage>
      <lpage>119</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: This study aimed to investigate the maturation and fertilization rates of immature mouse oocytes using Embryonic Stem Cell Conditioned Medium (ESCM).&lt;br /&gt;
Methods: Germinal Vesicle (GV) stage oocytes were observed in 120 NMRI mice, aged 4-6 weeks. GV oocytes with or without cumulus cells were subjected to IVM in either ESCM, Embryonic Stem Cell Growth Medium (ESGM), or &amp;alpha;-minimum essential medium (&amp;alpha;-MEM). After recording the Metaphase II (MII) oocyte maturation rate, the oocytes were fertilized&lt;em&gt; in vitro&lt;/em&gt;. The fertilization success rate was recorded after 24 &lt;em&gt;hr. &lt;/em&gt;The embryos were maintained in potassium Simplex Optimization Medium (KSOM) for 96 &lt;em&gt;hr&lt;/em&gt; and allowed to grow until the blastocyst stage. After recording developmental competence, they were transferred into the uteri of pseudopregnant mice and their birth rates were recorded.&lt;br /&gt;
Results: No significant difference existed between the maturation rates in &amp;alpha;-MEM (68.18%) and ESCM (64.67%; p&amp;gt;0.05), whereas this rate was significantly higher for both &amp;alpha;-MEM and ESCM compared to ESGM (32.22%; p&amp;lt;0.05). A significant difference in IVF success rate existed for oocytes grown in &amp;alpha;-MEM (69.44%), ESCM (61.53%), and ESGM (0%). A significantly higher developmental competence was observed at the blastocyst stage for oocytes grown in &amp;alpha;-MEM (51.2%) compared to ESCM (35%; p&amp;lt;0.05). 17 days after embryo transfer into the uteri of pseudopregnant mice, there was a nonsignficant (p&amp;gt;0.05), similar birth rate between &amp;alpha;-MEM and ESCM (47 &lt;em&gt;vs&lt;/em&gt;. 40%).&lt;br /&gt;
Conclusion: ESCM is an effective medium for preantral follicle growth, oocyte maturation, and subsequent embryo development.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
